Long non-coding RNA MAFG-AS1: A promising therapeutic target for human cancers
Long non-coding RNAs (lncRNAs) are commonly known for their important characters in cancer progression. LncRNA MAFG-antisense 1 (AS1) (MAFG-AS1) has been discovered as a novel oncogenic lncRNA for several years. Accumulating data have demonstrated abnormal overexpression of MAFG-AS1 in various human...
Main Authors: | Zhiyu Huang, Maoqing Zhang, Jiayue Li, Chenghua Lou |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-07-01
|
Series: | Biomedicine & Pharmacotherapy |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0753332223005450 |
Similar Items
-
LncRNA MAFG-AS1 is involved in human cancer progression
by: Penghui Li, et al.
Published: (2023-11-01) -
Correlation between long non-coding RNA MAFG-AS1 and cancer prognosis: a meta-analysis
by: Guangyao Lin, et al.
Published: (2023-12-01) -
Long Non-Coding RNA MAFG-AS1 as a Potential Biomarker for Hepatocellular Carcinoma: Linkage with Tumor Features, Markers, Liver Functions, and Survival Profile
by: Yuanyuan Tian, et al.
Published: (2022-05-01) -
Deficiency of the bZIP transcription factors Mafg and Mafk causes misexpression of genes in distinct pathways and results in lens embryonic developmental defects
by: Shaili D. Patel, et al.
Published: (2022-08-01) -
MAFG-AS1 is a prognostic biomarker and facilitates prostate cancer progression
by: Peizhang Li, et al.
Published: (2022-08-01)